Plain-English translation of NCT06922500 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a processed EEG monitor — a special brain-wave device that measures how deeply asleep you are — helps doctors manage anesthesia better during brain tumor removal surgery. The study compares two standard ways of delivering the anesthesia medications propofol and remifentanil: one method where the anesthesiologist manually adjusts the dose, and another where a computer algorithm calculates the ideal dose. The goal is to see which approach, combined with the brain monitor, keeps you at the right depth of anesthesia and helps you wake up faster and more safely after surgery.
During brain tumor surgery, doctors have limited ability to watch your face and eyes to judge how deeply asleep you are — the usual ways they monitor anesthesia. A brain-wave monitor could help fill this gap, reduce the risk of waking up during surgery, and prevent over-sedation so you recover faster and doctors can quickly check for any complications after your operation.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive your scheduled brain tumor removal surgery as planned. The main difference is that during surgery, doctors will use a special brain-wave monitor (attached with small stickers on your scalp) to track how deeply asleep you are, and you will randomly receive anesthesia using one of two standard delivery methods. You will also be monitored closely for how quickly you wake up and recover after surgery, with assessments of your neurological function. The study is comparing these two anesthesia approaches to see which works best with the brain monitor.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
Sweden